Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1633 1635 1656 1658
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18746105 | MODIFIED AAV CONSTRUCTS AND USES THEREOF | Non-Final OA | University of Massachusetts |
| 18025749 | RECOMBINANT ADENO ASSOCIATED VIRUS (RAAV) ENCODING GJB2 AND USES THEREOF | Non-Final OA | President and Fellows of Harvard College |
| 18483090 | COMPOUNDS, COMPOSITIONS, AND METHODS FOR USING HLA-F | Non-Final OA | THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL |
| 17786382 | LIGATION-BASED GENE EDITING USING CRISPR NICKASE | Final Rejection | Agilent Technologies, Inc. |
| 18291018 | GENERATION OF LARGE PROTEINS BY CO-DELIVERY OF MULTIPLE VECTORS | Non-Final OA | UNIVERSITY OF WASHINGTON |
| 18246981 | USE OF A DOUBLE-STRANDED DNA CYTOSINE DEAMINASE FOR MAPPING DNA-PROTEIN INTERACTIONS | Non-Final OA | University of Washington |
| 18626784 | TARGETED GENE THERAPY FOR DM-1 MYOTONIC DYSTROPHY | Non-Final OA | Genzyme Corporation |
| 18687385 | Modulation of TJPI Expression to Treat Liver Diseases | Non-Final OA | AGENCY FOR SCIENCE TECHNOLOGY AND RESEARCH |
| 18687892 | IVT RNA MANUFACTURING PROCESS | Non-Final OA | GLAXOSMITHKLINE BIOLOGICALS SA |
| 18454192 | TARGETED DNA DEMETHYLATION AND METHYLATION | Non-Final OA | The Jackson Laboratory |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy